Showing results (451-460 of 1,167) with videos related to
Sort By:
Pageof 117
Molecular Carcinogenesis|November 22, 2012
Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinomaXiaofeng Wu, Hairong Chen, Qiang Gao, et al.Journal of Gastroenterology|November 27, 2015
Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysisSheng-Li Yang, Li-Ping Liu, Yun-Fan Sun, et al.Oncotarget|January 11, 2015
Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinomaZhiao Chen, Xinyuan Lu, Zhichao Wang, et al.Journal of Nursing Care Quality|January 5, 2022
Bridging the Acute-to-Outpatient Care Gap in Mental Health: Developing and Implementing a Mental Health Transition ProcessTina Kantaria, Germiniano Talag, Jia Fan, et al.Biology Open|May 18, 2019
Blockage of glutamine-dependent anaplerosis affects mTORC1/2 activity and ultimately leads to cellular senescence-like responseGeng-You Liao, Ming-Ting Lee, Jhen-Jia Fan, et al.BMC Cancer|April 10, 2019
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resectionYang Lv, Xu Han, Xue-Feng Xu, et al.Asian Pacific Journal of Cancer Prevention : APJCP|January 22, 2015
Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinomaXiao-Chun Ni, Yong Yi, Yi-Peng Fu, et al.Cancer Medicine|February 15, 2023
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort studyMing-Hao Xu, Cheng Huang, Mei-Ling Li, et al.BMC Pharmacology & Toxicology|March 12, 2025
AMD1, a cardiotoxicity target for MaduramicinZi-Feng Xie, Han-Meng Liu, Jia-Fan Zhao, et al.International Journal of Surgery (London, England)|August 1, 2023
Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort studyWenju Chang, Yijiao Chen, Shizhao Zhou, et al.Pageof 117